Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma

被引：12
|
作者：
Kalac, Matko [1 ,2 ,11 ]
Jain, Salvia [3 ]
Tam, Constantine S. [4 ,5 ]
Xiao, Zhengrui [6 ]
Montanari, Francesca [7 ]
Kanakry, Jennifer [8 ]
Huber, Bryan D. [9 ]
Goldfinger, Mendel [6 ]
O'Connor, Owen A.
Marchi, Enrica [10 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Hematol & Oncol, New York, NY USA
[2] Univ Calif Irvine, Dept Hematol & Oncol, Irvine, CA USA
[3] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[4] Monash Univ, Melbourne, Vic, Australia
[5] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia
[6] Albert Einstein Coll Med, Dept Med, New York, NY USA
[7] Yale Univ Canc Ctr, Dept Hematol, Greenwich, CT USA
[8] NCI, Expt Transplantat & Immunotherapy Branch, NIH, Bethesda, MD USA
[9] Intermt Med Grp, Blood & Marrow Transplant Acute Leukemia Program, Salt Lake City, UT USA
[10] Univ Virginia Canc Ctr, Div Hematol & Oncol, Charlottesville, VA USA
[11] Univ Calif Irvine, Tisch Canc Inst, 200 S Manchester Ave, Orange, CA 92868 USA
来源：
BLOOD ADVANCES | 2023年 / 7卷 / 14期
关键词：
MUTATIONS; TET2;
D O I：
10.1182/bloodadvances.2022009445
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3760 / 3763
页数：4
相关论文
共 50 条
  • [31] Efficacy and Safety Analysis of Venetoclax Combined with Azacitidine in Real-World Treatment of Patients with AML
    Huang, Xin
    Deng, Chengxin
    Li, Minming
    Lu, Zesheng
    Wu, Ping
    Luo, Qiong
    Geng, Suxia
    Zeng, Lingji
    Wang, Yulian
    Zhou, Hui
    Weng, Jianyu
    Du, Xin
    BLOOD, 2023, 142
  • [32] Application patterns and outcomes of hematopoietic stem cell transplantation in peripheral T-cell lymphoma patients: a multicenter real-world study in China
    Gao, Hongye
    Zhang, Zhuoxin
    Wang, Jiali
    Jia, Yannan
    Zheng, Yawei
    Pei, Xiaolei
    Zhai, Weihua
    Zhang, Rongli
    Chen, Xin
    Ma, Qiaoling
    Wei, Jialin
    Yang, Donglin
    Pang, Aiming
    He, Yi
    Feng, Sizhou
    Zhang, Hao
    Du, Xin
    Song, Xianmin
    Liu, Yao
    Zou, Dehui
    Jiang, Erlie
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [33] A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
    Strati, Paolo
    Chihara, Dai
    Oki, Yasuhiro
    Fayad, Luis E.
    Fowler, Nathan
    Nastoupil, Loretta
    Romaguera, Jorge E.
    Samaniego, Felipe
    Garg, Naveen
    Feng, Lei
    Wesson, Emily T.
    Ruben, Charnelle E.
    Stafford, Mildred D.
    Nieto, Yago
    Khouri, Issa F.
    Hosing, Chitra
    Horowitz, Sandra B.
    T-Kamble, Rammurti
    Fanale, Michelle A.
    HAEMATOLOGICA, 2018, 103 (09) : E416 - E418
  • [34] REAL-WORLD EXPERIENCE OF CAR T-CELL THERAPY: A SINGLE CENTRE EXPERIENCE
    Llanos, Francys Lopez
    Rocha, Ines
    Teixeira, Gilda
    Ferreira, Isabelina
    Sousa, Pedro
    Gutierrez, Maria Joao
    Pereira, Susana
    Freitas, Ana Carolina
    Espadinha, Carla
    Miranda, Nuno
    BONE MARROW TRANSPLANTATION, 2024, 59 : 211 - 211
  • [35] Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy
    Duvic, Madeleine
    Bates, Susan E.
    Piekarz, Richard
    Eisch, Robin
    Kim, Youn H.
    Lerner, Adam
    Robak, Tadeusz
    Samtsov, Alexey
    Becker, Juergen C.
    McCulloch, William
    Waksman, Joel
    Whittaker, Sean
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 880 - 887
  • [36] Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western Australia
    Kuzich, James A.
    Hutchison, Andrew P.
    Lim, Kenneth J. C.
    Smallbone, Portia
    Denning, Kate
    Wright, Matthew P.
    Cull, Gavin
    Leah, Michael F.
    Joske, David J. L.
    Radeski, Dejan
    Purtill, Duncan
    LEUKEMIA & LYMPHOMA, 2019, 60 (14) : 3417 - 3425
  • [37] Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma
    Mitteldorf, C.
    de Masson, A.
    Beylot-Barry, M.
    Wobster, M.
    Zomas, A.
    Stache, V.
    Assaf, C.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S77 - S78
  • [38] Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma
    Chihara, Dai
    Liao, Laura
    Tkacz, Joseph
    Franco, Anjali
    Lewing, Benjamin
    Kilgore, Karl M.
    Nastoupil, Loretta J.
    Chen, Lei
    BLOOD, 2023, 142 (12) : 1047 - 1055
  • [39] Romidepsin (Istodax) for Cutaneous T-Cell Lymphoma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1339): : 42 - 43
  • [40] Development of novel backbones for the treatment of peripheral T-cell lymphoma (PTCL): The pralatrexate/romidepsin doublet.
    Amengual, Jennifer Effie
    Lichtenstein, Renee
    Rojas, Celeste
    Sawas, Ahmed
    Deng, Changchun
    Colbourn, Donald Steven
    Lichtenstein, Emily
    Khan, Karen
    Smith, Michael J.
    Dials, Heather
    O'Connor, Owen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345